Header cover image

Danish Biotech Stocks

Results

7

0 new

Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.

7 companies

Novo Nordisk

Market Cap: DKK 1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

NOVO B

DKK 325.25

7D

-1.9%

1Y

-49.1%

Genmab

Market Cap: DKK 124.9b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

GMAB

DKK 2,027.00

7D

-4.5%

1Y

32.4%

H. Lundbeck

Market Cap: DKK 41.4b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

HLUN B

DKK 43.16

7D

0.4%

1Y

2.8%

Zealand Pharma

Market Cap: DKK 32.9b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

ZEAL

DKK 466.40

7D

-3.4%

1Y

-35.9%

Bavarian Nordic

Market Cap: DKK 14.9b

Develops, manufactures, and supplies life-saving vaccines.

BAVA

DKK 190.85

7D

0.7%

1Y

-4.0%

Gubra

Market Cap: DKK 8.5b

A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.

GUBRA

DKK 517.50

7D

0.1%

1Y

-17.1%

Strategic Partners

Market Cap: DKK 29.1m

Does not have significant operations.

STRAP

DKK 698.00

7D

1.5%

1Y

-14.4%